Christopher R. Cline, CFO: Travere Therapeutics TVTX Sell · Filed 24/09/09

Trade details

Type: Insider sale
Amount: $28,684.8
Shares · price: 2,490 sh · $11.52 a share
Held after: 74,595 sh
Stock: Travere Therapeutics TVTX
Person: Christopher R. ClineCFO
Trade date: 24/09/09
Filed: 24/09/09
Days to filing: 0 days

Sold 3.2% of holdings

Share of holding sold: 3.2%

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 24/08/10~24/10/09

Christopher R. Cline's recent trades

Christopher R. ClineCFO
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$3.3M
50,508 sh
$3.3M
Filed 09/15
Traded 09/15
Christopher R. ClineCFO
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$101.7K
2,181 sh
$101.7K
Filed 05/06
Traded 05/05
Christopher R. ClineCFO
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$13.6K
310 sh
$13.6K
Filed 05/06
Traded 05/06
Christopher R. ClineCFO
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$13.6K
310 sh
$13.6K
Filed 05/06
Traded 05/06
Christopher R. ClineCFO
Planned saleTravere Therapeutics
Planned sale
Travere Therapeutics
TVTX
$101.7K
2,181 sh
$101.7K
Filed 05/05
Traded 05/05